Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program
- 14 February 2002
- journal article
- case report
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 42 (2), 137-139
- https://doi.org/10.1016/s0732-8893(01)00333-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Susceptibility testing with linezolid by different methods, in relation to published 'general breakpoints': J Antimicrob Chemother 2001; 48: 452-454Journal of Antimicrobial Chemotherapy, 2001
- Linezolid resistance in a clinical isolate of Staphylococcus aureusThe Lancet, 2001
- Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparisonJournal of Antimicrobial Chemotherapy, 2001
- Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox® Antimicrobial Potency Study (ZAPS) in the United StatesDiagnostic Microbiology and Infectious Disease, 2001
- Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolidThe Lancet, 2001
- Susceptibility of Gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolidJournal of Antimicrobial Chemotherapy, 2000
- OxazolidinonesDrugs, 2000